Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare20. Clement JG, Broxup B. Efficacy of diazepam and avizafone against soman-induced neuropathology in brain of rats.Neurotoxicology. 1993;14:485–504.21. Hayward IJ, Wall HG, Jaax NK, Wade JV, Marlow DD, Nold JB. Decreased brain pathology in organophosphate-exposedrhesus monkeys following benzodiazepine therapy. J Neurol Sci. 1990;98:99–106.22. McDonough JH Jr, Dochterman LW, Smith CD, Shih TM. Protection against nerve agent-induced neuropathology, but notcardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology. 1995;16:123–132.23. Baze WB. Soman-induced morphological changes: an overview in the non-human primate. J Appl Toxicol. 1993;13:173–177.24. Olney JW, de Gubareff T, Labruyere J. Seizure-related brain damage induced by cholinergic agents. Nature. 1983;301:520–522.25. Sloviter RS. “Epileptic” brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acuteelectrophysiological and light microscopic studies. Brain Res Bull. 1983;10:675–697.26. Meldrum BS. Concept of activity-induced cell death in epilepsy: historical and contemporary perspectives. ProgressBrain Res. 2002;135:3–11.27. Fanzone JF, Levine ES, Hursh SR. Nerve Agent Bioscavenger Pretreatment Against Chemical Warfare Agents: Challenge,Casualty, and Intervention Modeling Support. Aberdeen Proving Ground, Md: US Army Medical Research and MaterielCommand. Interim Report. Contract No. DAMD17-98-D-0022; 2002.28. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsivestatus epilepticus. Epilepsia. 1998;39:833–840.29. Petras JM. Soman neurotoxicity. Fundam Appl Toxicol. 1981;1:242.30. Lemercier G, Carpentier P, Sentenac-Roumanou H, Morelis P. Histological and histochemical changes in the centralnervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol(Berl). 1983;61:123–129.31. McLeod CG Jr, Singer AW, Harrington DG. Acute neuropathology in soman poisoned rats. Neurotoxicology. 1984;5:53–57.32. Carpentier P, Delamanche IS, Le Bert M, Blanchet G, Bouchaud C. Seizure-related opening of the blood-brain barrierinduced by soman: possible correlation with the acute neuropathology observed in poisoned rats. Neurotoxicology.1990;11:493–508.33. Kadar T, Cohen G, Sahar R, Alkalai D, Shapira S. Long-term study of brain lesions following soman, in comparisonto DFP and metrazol poisoning. Hum Exp Toxicol. 1992; 11:517–523.34. McDonough JH Jr, McLeod CG Jr, Nipwoda MT. Direct microinjection of soman or VX into the amygdala producesrepetitive limbic convulsions and neuropathology. Brain Res. 1987;435:123–137.35. Pazdernik TL, Cross R, Giesler M, Nelson S, Samson F, McDonough J Jr. Delayed effects of soman: brain glucose useand pathology. Neurotoxicology. 1985;6:61–70.36. Petrali JP, Maxwell DM, Lenz DE, Mills KR. Effect of an anticholinesterase compound on the ultrastructure and functionof the rat blood-brain barrier: a review and experiment. J Submicrosc Cytol Pathol. 1991;23:331–338.37. Petras JM. Neurology and neuropathology of soman-induced brain injury: an overview. J Exp Anal Behav. 1994;61:319–329.38. Ballough GP, Martin LJ, Cann FJ, et al. Microtubule-associated protein 2 (MAP-2): a sensitive marker of seizure-relatedbrain damage. J Neurosci Methods. 1995;61:23–32.234